Gri Bio Inc.
05/05/2025 | Press release | Distributed by Public on 05/05/2025 05:36
Material Event (Form 8-K)
Item 8.01 Other Events.
On May 5, 2025, GRI Bio, Inc. (the "Company") filed a prospectus supplement to increase the maximum number of shares (the "Shares") of the Company's common stock, par value $0.0001 per share, issuable pursuant to the At The Market Offering Agreement between the Company and H.C. Wainwright & Co., LLC, dated May 20, 2024 (the "Sales Agreement"), to up to an aggregate of $1,670,956 of Shares, which does not include the Shares having an aggregate gross sales price of approximately $3,604,683 that have been sold to date under the Sales Agreement.
Attached hereto as Exhibit 5.1 to this Current Report is the opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., relating to the legality of the issuance and sale of the Shares.
Gri Bio Inc. published this content on May 05, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on May 05, 2025 at 11:36 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io